# Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

> **NCT03082768** · EARLY_PHASE1 · COMPLETED · sponsor: **Molecular NeuroImaging** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [18F]MNI-968

## Key facts

- **NCT ID:** NCT03082768
- **Lead sponsor:** Molecular NeuroImaging
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-03
- **Primary completion:** 2018-03-01
- **Final completion:** 2018-03-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082768, "Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03082768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*